Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

Mon, 08th Oct 2018 12:00

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a drastic 3% decline in Chinese indices providing an overwhelmingly bearish tone for early European trade. The decision from the Chinese central bank to reduce the amount of capital banks require to hold is expected to free up USD109 billion for the economy, this also highlights the expectation of further economic suffering in the country, with the US-China trade war looking likely to rumble on," said IG market analyst Joshua Mahony.Halma and Vodafone were among the fallers in the FTSE 100 on Monday, while insurers were bringing up the rear of the FTSE 250 following an update from Lancashire Holdings.The FTSE 100 was down 0.6%, or 44.64 points, at 7,273.90 by midday. The FTSE 250 was 0.6% lower, or 126.82 points, at 19,791.21. The AIM All-Share was down 1.3% at 1,055.14.The Cboe UK 100 was 0.7% lower at 12,344.24 and the Cboe UK 250 also declined 0.7% to 17,953.56, while the Cboe UK Small Companies was down 0.1% at 12,007.53.Over in mainland Europe at midday, the CAC 40 in Paris and DAX 30 in Frankfurt were both 0.8% lower.The biggest faller in the FTSE 100 on Monday was Halma, down 3.5% after Shore Capital downgraded the hazard detection firm to Hold from Buy. Another of Monday's losers, Vodafone, was also lower after a broker downgrade. Jefferies cut its rating on the telecommunications stock to Hold from Buy, leaving Vodafone shares trading down 2.4%.Meanwhile, Segro gained 1.7% after Goldman Sachs raised the property investor and developer to Buy from Neutral.Insurers were among those falling in the FTSE 250 following a third quarter warning from Lancashire Holdings, the stock down 5.5%.The insurer said it expects to post a negative return on equity for the third quarter of 2018 due to losses from a number of recent natural disasters including hurricane Florence and typhoons Jebi, Mangkhut and Trami. Lancashire, which provides specialty insurance and reinsurance products, estimates losses from recent natural catastrophe events to be in a range of USD25 million to USD45 million. It also expects to record a USD30 million net loss from its marine portfolio. Other insurers were hit in a negative read-across following the update, with Hiscox down 1.8% and Beazley down 3.3%.IP Group was down 3.0% after reporting that its portfolio company, Diurnal, did not see Chronocort meet its primary objective in a phase three trial.Chronocort is intended to treat congenital adrenal hyperplasia, an orphan condition in which patients have a block in cortisol production. The goal of the phase three trial was to "demonstrate the superiority of Chronocort to conventional therapy", a goal which was not met as both Chronocort and conventional therapy proved equivalent.Shares in Diurnal were a steep 61% lower at midday.Shares in fashion retailer French Connection jumped 29% as it mulled a sale of the business."The board confirms it is currently reviewing all strategic options in order to deliver maximum value for its shareholders, which includes the potential sale of the company," the struggling retailer said in a statement responding to weekend press reports.French Connection, however, added that there can be no certainty over an offer, nor as to the terms of any offer.In September, French Connection recorded a widened loss in the first half of its 2019 financial year on the back of store closures and a "tough" retail trading environment in the UK."French Connection has long been seen as a value trap - the business contains hidden value but ongoing problems with trading have seen the share price remain weak. A sale of the business could help to lift it out of the 'trap' as long as the suitor is prepared to invest some time and money in sorting out the bad bits and nurturing the good bits," commented Russ Mould, investment director at AJ Bell.In data on Monday, a quarterly survey from the British Chambers of Commerce said the UK economy is stuck in a rut due to Brexit uncertainties.The balance of manufacturing firms reporting a fall in domestic sales rose to 24, while that of services firms fell to 23. Domestic orders for manufacturing declined, while services reported improved domestic orders.In services, the export sales balance fell marginally to 14 and export orders held steady at 12 in the third quarter.The lobby warned that the slowdown in exports in the manufacturing sector, and many services firms seemingly giving up trying to hire new staff, should be cause for concern."There has never been a more important time for the government to bolster business investment, competitiveness and productivity, in the face of significant Brexit headwinds," Adam Marshall, Director General of the BCC said.Elsewhere, Chinese Foreign Minister Wang Yi gave US Secretary of State Mike Pompeo a cool reception Monday in Beijing, as he warned of "conflict and confrontation" between the two world powers.Wang told Pompeo the US has escalated trade frictions between the two economies, and undermined China's interests on issues such as Taiwan and other domestic and foreign policies, the state-owned China Daily reported."We demand the US stop the unwarranted accusations and wrongdoings against China immediately," Wang said, warning against the US "taking a wrong approach of conflict and confrontation."Pompeo is on an East Asia tour focused on deciding the next steps in North Korea's denuclearization.In the US on Monday, stock markets remain open as the Columbus Day is observed. The Dow Jones is called 0.3% lower, with the S&P 500 set to shed 0.2% and the Nasdaq seen tumbling a steep 1.4% at the open.While the US corporate and economic calendar is quiet on Monday, things begin to kick off at the end of the week with the start of third quarter earnings season. Results are due from banks such as Citigroup, JPMorgan Chase and Wells Fargo on Friday.
More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.